NCT03058081View on ClinicalTrials.gov

Effect of High Flow Nasal During Exercise in COPD Patients

NACompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

August 1, 2017

Primary Completion Date

June 18, 2018

Study Completion Date

June 18, 2018

Conditions
COPD Exacerbation
Interventions
DEVICE

High Flow nasal cannula

High intensity Constant Work-Rate exercise test with High Flow Nasal Cannula in COPD patients involved in a Pulmonary Rehabilitation Program after an exacerbation (\< 7 days after hospital discharge). High Flow nasal will be administered through nasal cannula using the Airvo2 (Fisher\&Paykel)

Trial Locations (1)

76290

Groupe Hospitalier du Havre, Montivilliers

All Listed Sponsors
lead

Groupe Hospitalier du Havre

OTHER

NCT03058081 - Effect of High Flow Nasal During Exercise in COPD Patients | Biotech Hunter | Biotech Hunter